Biologic treatment of human cancer
Authors:
- Louis M. WeinerLWLouis M. Weiner
- 1 July 1995
- journal article
- review article
- Published by Elsevier in Current Problems in Cancer
- Vol. 19 (4) , 190-261
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Idiotypic cascade in the human high molecular weight melanoma‐associated antigen system: Fine specificity and idiotypic profile of anti‐anti‐idiotypic monoclonal antibodiesEuropean Journal of Immunology, 1993
- Interleukin 2 treatment in acute myelogenous leukemiaStem Cells, 1993
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2aCancer Immunology, Immunotherapy, 1992
- Phase I Trial of Interleukin-2 plus Gamma-InterferonJournal of Immunotherapy, 1992
- The out-patient use of recombinant human interleukin-2 and interferon alfa-2b in advanced malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensinInternational Journal of Cancer, 1989
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- IMMUNOLOGICAL DETERMINANTS OF POLYOMA VIRUS ONCOGENESISJournal of Experimental Medicine, 1962